SEC Form 4 · Updated Daily
AKUS
Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| NOVARTIS AG | 10%+ Owner | 1,181,258 | 2020-06-30 | P |
| Novartis Bioventures Ltd | 10%+ Owner | 1,181,258 | 2020-06-30 | P |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2020-06-30 | NOVARTIS AG | Conversion (derivative) | 199,996 | $0.00 | 0 |
| 2020-06-30 | NOVARTIS AG | Conversion (derivative) | 856,262 | $0.00 | 0 |
| 2020-06-30 | NOVARTIS AG | Open-market buy | 125,000 | $17.00 | 1,181,258 |
| 2020-06-30 | NOVARTIS AG | Conversion | 199,996 | — | 1,056,258 |
| 2020-06-30 | NOVARTIS AG | Conversion | 856,262 | — | 856,262 |
| 2020-06-30 | Novartis Bioventures Ltd | Conversion (derivative) | 199,996 | $0.00 | 0 |
| 2020-06-30 | Novartis Bioventures Ltd | Conversion (derivative) | 856,262 | $0.00 | 0 |
| 2020-06-30 | Novartis Bioventures Ltd | Open-market buy | 125,000 | $17.00 | 1,181,258 |
| 2020-06-30 | Novartis Bioventures Ltd | Conversion | 199,996 | — | 1,056,258 |
| 2020-06-30 | Novartis Bioventures Ltd | Conversion | 856,262 | — | 856,262 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.